Literature DB >> 8591623

Fibrin glue for sealing the needle track after percutaneous lung biopsy: Part I--Experimental study.

T Petsas1, P J Vassilakos, D Dougenis, C Giannakenas, C D Scopa, K Vasiou, I Fezoulidis.   

Abstract

PURPOSE: Evaluate the effectiveness of fibrin glue for the embolic occlusion of needle tracks following percutaneous lung biopsy (PLB).
METHODS: Twenty-six rabbits underwent computed tomography (CT)-guided PLB using a coaxial system consisting of 19- and 22-gauge needles. Thirteen rabbits were used as controls (group A). In 13 other rabbits (group B), fibrin glue labelled with I131 fibrinogen and contrast medium was injected into the track. Both groups were examined by CT for the presence and severity of pneumothorax (mild: less than 20%; severe: more than 20%). Group B was also examined scintigraphically and their lungs were studied histologically.
RESULTS: In group A, pneumothorax developed in eight animals (61.6%) and was severe in six (46.1%) whereas in group B, pneumothorax developed in five animals (38.5%) and was severe in one (7.7%). Though the difference between the two groups in overall incidence of pneumothorax was not significant (p > 0.1), it was significantly higher (p < 0.025) for severe pneumothorax in group A. No signs of systemic embolism were observed.
CONCLUSIONS: Based on this animal model, fibrin glue is a safe and useful sealant following PLB and reduces the incidence of severe pneumothorax.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8591623     DOI: 10.1007/bf00338304

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  15 in total

1.  [The use of homologous coagulated blood for prevention of pneumothorax following percutaneous lung biopsy (experimental study)].

Authors:  T Petsas; I Fezoulidis; D Siamplis; I Dimopoulos
Journal:  Rofo       Date:  1990-05

Review 2.  Percutaneous transthoracic needle biopsy.

Authors:  J L Westcott
Journal:  Radiology       Date:  1988-12       Impact factor: 11.105

3.  Transthoracic needle aspiration biopsy: evaluation of the blood patch technique.

Authors:  P M Bourgouin; J A Shepard; T C McLoud; D L Spizarny; C G Dedrick
Journal:  Radiology       Date:  1988-01       Impact factor: 11.105

4.  Air embolism complicating percutaneous lung biopsy.

Authors:  T L Tolly; J E Feldmeier; D Czarnecki
Journal:  AJR Am J Roentgenol       Date:  1988-03       Impact factor: 3.959

5.  Complications of transthoracic needle biopsy decreased with isobutyl 2-cyanoacrylate: a pilot study.

Authors:  A Skupin; F Gomez; M Husain; C Skupin; O Bigman
Journal:  Ann Thorac Surg       Date:  1987-04       Impact factor: 4.330

6.  Homologous controlled-viscosity fibrin for endovascular embolization. Part I. Experimental development of the medium.

Authors:  B Richling
Journal:  Acta Neurochir (Wien)       Date:  1982       Impact factor: 2.216

7.  A technique for the prevention of pneumothorax in pulmonary aspiration biopsy.

Authors:  R McCartney; D Tait; M Stilson; G F Seidel
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1974-04

8.  Evaluation of fibrin seal in animal experiments.

Authors:  A Haverich; W Maatz; G Walterbusch
Journal:  Thorac Cardiovasc Surg       Date:  1982-08       Impact factor: 1.827

9.  Usefulness of the blood patch technique after transthoracic needle aspiration biopsy.

Authors:  S J Herman; G L Weisbrod
Journal:  Radiology       Date:  1990-08       Impact factor: 11.105

10.  Postbiopsy pneumothorax: estimating the risk by chest radiography and pulmonary function tests.

Authors:  G D Fish; J H Stanley; K S Miller; S I Schabel; S E Sutherland
Journal:  AJR Am J Roentgenol       Date:  1988-01       Impact factor: 3.959

View more
  1 in total

1.  Systemic air embolism during percutaneous core needle biopsy of the lung: frequency and risk factors.

Authors:  Martin C Freund; Johannes Petersen; Katharina C Goder; Tillmann Bunse; Franz Wiedermann; Bernhard Glodny
Journal:  BMC Pulm Med       Date:  2012-02-06       Impact factor: 3.317

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.